Literature DB >> 32602593

Machine learning and artificial intelligence in haematology.

Roni Shouval1,2, Joshua A Fein3, Bipin Savani4, Mohamad Mohty5,6, Arnon Nagler2.   

Abstract

Digitalization of the medical record and integration of genomic methods into clinical practice have resulted in an unprecedented wealth of data. Machine learning is a subdomain of artificial intelligence that attempts to computationally extract meaningful insights from complex data structures. Applications of machine learning in haematological scenarios are steadily increasing. However, basic concepts are often unfamiliar to clinicians and investigators. The purpose of this review is to provide readers with tools to interpret and critically appraise machine learning literature. We begin with the elucidation of standard terminology and then review examples in haematology. Guidelines for designing and evaluating machine-learning studies are provided. Finally, we discuss limitations of the machine-learning approach.
© 2020 British Society for Haematology and John Wiley & Sons Ltd.

Keywords:  artificial intelligence; haematology; leukaemia; machine learning; prediction models

Year:  2020        PMID: 32602593     DOI: 10.1111/bjh.16915

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Overcoming resistance to targeted therapies in chronic lymphocytic leukemia.

Authors:  Sigrid S Skånland; Anthony R Mato
Journal:  Blood Adv       Date:  2021-01-12

2.  Rapid triage for ischemic stroke: a machine learning-driven approach in the context of predictive, preventive and personalised medicine.

Authors:  Yulu Zheng; Zheng Guo; Yanbo Zhang; Jianjing Shang; Leilei Yu; Ping Fu; Yizhi Liu; Xingang Li; Hao Wang; Ling Ren; Wei Zhang; Haifeng Hou; Xuerui Tan; Wei Wang
Journal:  EPMA J       Date:  2022-05-27       Impact factor: 8.836

3.  A Deep Learning Approach for the Morphological Recognition of Reactive Lymphocytes in Patients with COVID-19 Infection.

Authors:  José Rodellar; Kevin Barrera; Santiago Alférez; Laura Boldú; Javier Laguna; Angel Molina; Anna Merino
Journal:  Bioengineering (Basel)       Date:  2022-05-23

4.  Artificial Intelligence to Detect Meibomian Gland Dysfunction From in-vivo Laser Confocal Microscopy.

Authors:  Ye-Ye Zhang; Hui Zhao; Jin-Yan Lin; Shi-Nan Wu; Xi-Wang Liu; Hong-Dan Zhang; Yi Shao; Wei-Feng Yang
Journal:  Front Med (Lausanne)       Date:  2021-11-25

5.  Reference Intervals for Blood Biomarkers in Farmed Atlantic Salmon, Coho Salmon and Rainbow Trout in Chile: Promoting a Preventive Approach in Aquamedicine.

Authors:  Marco Rozas-Serri; Rodolfo Correa; Romina Walker-Vergara; Darling Coñuecar; Soraya Barrientos; Camila Leiva; Ricardo Ildefonso; Carolina Senn; Andrea Peña
Journal:  Biology (Basel)       Date:  2022-07-18

6.  Integrating artificial intelligence into haematology training and practice: Opportunities, threats and proposed solutions.

Authors:  Shang Yuin Chai; Amjad Hayat; Gerard Thomas Flaherty
Journal:  Br J Haematol       Date:  2022-07-04       Impact factor: 8.615

Review 7.  Predictive models for clinical decision making: Deep dives in practical machine learning.

Authors:  Sandra Eloranta; Magnus Boman
Journal:  J Intern Med       Date:  2022-04-25       Impact factor: 13.068

8.  Translational Applications of Artificial Intelligence and Machine Learning for Diagnostic Pathology in Lymphoid Neoplasms: A Comprehensive and Evolutive Analysis.

Authors:  Julia Moran-Sanchez; Antonio Santisteban-Espejo; Miguel Angel Martin-Piedra; Jose Perez-Requena; Marcial Garcia-Rojo
Journal:  Biomolecules       Date:  2021-05-25

Review 9.  The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms.

Authors:  Tanja Belčič Mikič; Tadej Pajič; Samo Zver; Matjaž Sever
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

Review 10.  How artificial intelligence might disrupt diagnostics in hematology in the near future.

Authors:  Wencke Walter; Claudia Haferlach; Niroshan Nadarajah; Ines Schmidts; Constanze Kühn; Wolfgang Kern; Torsten Haferlach
Journal:  Oncogene       Date:  2021-06-08       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.